Combination of statin and ezetimibe for the treatment of dyslipidemias and the prevention of coronary artery disease-Reference-Cited by-同舟云学术

Combination of statin and ezetimibe for the treatment of dyslipidemias and the prevention of coronary artery disease

Published:2006-08 Issue:10 Volume:22 Page:863-868
ISSN:0828-282X
Container-title:Canadian Journal of Cardiology
language:en
Short-container-title:Canadian Journal of Cardiology

Author:

Genest Jacques

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference37 articles.

1. Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines;Grundy;Circulation,2004

2. Recommendations for the management and treatment of dyslipidemia and prevention of cardiovascular disease: Summary of the 2003 update;Genest;CMAJ,2003

3. Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group Recommendations;Davidson;Am J Cardiol,2005

4. Statin therapy in Canadian patients with hypercholesterolemia: The Canadian Lipid Study–Observational (CALIPSO) study;Bourgault;Can J Cardiol,2005

5. Intensive versus moderate lipid lowering with statins after acute coronary syndromes;Cannon;N Engl J Med,2004

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ApoB100 and Atherosclerosis: What’s New in the 21st Century?;Metabolites;2024-02-12

2. Positioning of PCSK9 Inhibitors in hypercholesterolemia;Indian Journal of Pharmacy and Pharmacology;2023-10-15

3. Ezetimibe Induces Vasodilation in Rat Mesenteric Resistance Arteries through Inhibition of Extracellular Ca2+ Influx;International Journal of Molecular Sciences;2023-09-12

4. The prevalence and treatment patterns of familial hypercholesterolemia among Thai patients with premature coronary artery disease;Postgraduate Medicine;2023-02-27

5. Impact of lipid-lowering drugs on lipid profile in hyperlipidemia patients;Medical Journal of Babylon;2023